Tian'an Pharmaceutical Co Statistics
Tian'an Pharmaceutical Co (TNPH) Stock Statistics & Valuation Metrics
Total Valuation
Tian'an Pharmaceutical Co has a market cap or net worth of $24.00M. The enterprise value is $209.88B.
- Market Cap
- $24.00M
- Enterprise Value
- $209.88B
Share Statistics
Tian'an Pharmaceutical Co has 800,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 800,000,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Tian'an Pharmaceutical Co’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 16.17%.
- Return on Equity (ROE)
- 0.05
- Return on Assets (ROA)
- -0.68
- Return on Invested Capital (ROIC)
- 16.17%
- Return on Capital Employed (ROCE)
- 0.05
- Revenue Per Employee
- 0
- Profits Per Employee
- -1,545.667
- Employee Count
- 3
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Tian'an Pharmaceutical Co is -1961.10. Tian'an Pharmaceutical Co’s PEG ratio is -19.61.
- PE Ratio
- -1961.10
- PS Ratio
- 0.00
- PB Ratio
- -221.03
- Price to FCF
- -2758.62
- Price to Operating Cash Flow
- -2760.21
- PEG Ratio
- -19.61
Income Statement
In the last 12 months, Tian'an Pharmaceutical Co had revenue of 0 and earned -4,637 in profits. Earnings per share was 0.00.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -4,637
- Pretax Income
- -4,637
- Net Income
- -4,637
- EBITDA
- -4,637
- Earnings Per Share (EPS)
- 0.00
Cash Flow
In the last 12 months, operating cash flow was -8,695 and capital expenditures -5, giving a free cash flow of -8,700 billion.
- Operating Cash Flow
- -8,695
- Free Cash Flow
- -8,700
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Tian'an Pharmaceutical Co pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -0.04%
- Earnings Yield
- -0.05%
Stock Price Statistics
- Beta
- 1.20
- 52-Week Price Change
- 57.89%
- 50-Day Moving Average
- 0.03
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- 85.61
- Average Volume (3m)
- 29.43K
Financial Position
Tian'an Pharmaceutical Co as a current ratio of 0.06, with Debt / Equity ratio of -71.40%
- Current Ratio
- 0.06
- Quick Ratio
- 0.06
- Debt to Market Cap
- 0.03
- Net Debt to EBITDA
- -15.44
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Tian'an Pharmaceutical Co has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Tian'an Pharmaceutical Co EV to EBITDA ratio is -1966.35, with an EV/FCF ratio of -2766.00.
- EV to Sales
- 0.00
- EV to EBITDA
- -1966.35
- EV to Free Cash Flow
- -2766.00
- EV to Operating Cash Flow
- -2767.59
Balance Sheet
Tian'an Pharmaceutical Co has -$82.00 in cash and marketable securities with $64.11K in debt, giving a net cash position of -$64.19K billion.
- Cash & Marketable Securities
- -$82.00
- Total Debt
- $64.11K
- Net Cash
- -$64.19K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Tian'an Pharmaceutical Co is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
